AGTX
AGENTIX CORP by Agentix Corp. (AGTX)
$04
About AGENTIX CORP by Agentix Corp. (AGTX)
Agentix Corp.is a biotechnology company, which engages in the development and commercialization of novel therapeutics to treat metabolic diseases, peripheral neuropathy, progressive lung disease, and ischemic reperfusion injury. It is focused on the development of synthetic agonists, inverse agonists, and antagonists which modulate the endocannabinoid system (ECS). The company was founded on April 18, 2013 and is headquartered in Dana Point, CA.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.20
52 Week Low
$0.02
Market cap
1.7M
Dividend yield
0.00%
Volume
--
Avg. volume
2,153
P/E ratio
-2.59
AGENTIX CORP by Agentix Corp. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.20
52 Week Low
$0.02
Market cap
1.7M
Dividend yield
0.00%
Volume
--
Avg. volume
2,153
P/E ratio
-2.59